Missouri Roundup Cancer Claims After the Supreme Court’s FIFRA Preemption Ruling
You heard the news and your stomach dropped. The Supreme Court ruled for Bayer. The headline said it — Roundup lawsuits are being reined in. And if you are one of the thousands of people in Missouri who used that weedkiller for years and then heard the words “non-Hodgkin’s lymphoma” from an oncologist, you probably thought your case just died on the steps of the Supreme Court.
It did not. But the ground underneath it shifted, and how far it shifted depends on facts specific to your situation — the kind of facts that require a lawyer who has read the actual ruling, not the headline.
Here is what we want you to understand before you read one more word of this page: the Supreme Court did not say Roundup is safe. It did not say glyphosate does not cause cancer. It did not say you cannot sue. It answered one narrow legal question — whether federal pesticide law blocks states from requiring a cancer warning on the label that the federal government never required — and seven of nine justices said yes to that one question. That answer closes one road. It does not close every road. And the $7.25 billion settlement Bayer announced is still on the table for many claimants, separate from anything the Supreme Court decided.
We are Attorney911 — The Manginello Law Firm, PLLC. We handle toxic tort and product liability cases, and we take cases in Missouri, working with local counsel where required. This page is the honest, complete analysis of what the ruling means for someone in your position — not a sales pitch, not false hope, and not surrender. If you are reading this at 2 a.m. wondering whether it is still worth making the call, the answer is on this page. Keep reading.
What the Supreme Court Actually Ruled — and What It Did Not Say
The Court took up the case to answer a single, precise question. The article reporting the ruling describes the question the justices were asked to decide:
“Whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts a label-based failure-to-warn claim where the Environmental Protection Agency (EPA) has not required the warning.”
Seven justices answered that question yes. Two answered no. Here is what that means in plain English.
FIFRA is the federal law that governs how pesticides are registered, labeled, sold, and used in the United States. Under FIFRA, the EPA reviews pesticide labels before a product can be distributed. The EPA reviewed glyphosate — the active ingredient in Roundup — and concluded it is “not likely to be carcinogenic to humans when used according to label instructions.” The EPA did not require a cancer warning on the Roundup label. The Supreme Court held that because the EPA made that decision within a comprehensive federal labeling framework, individual states cannot override it by requiring a different or additional warning through their own tort laws. States cannot demand more on the label than the federal regulator required.
That is the holding. Now let us be precise about what the holding does NOT say:
The Court did not rule on whether glyphosate causes cancer. The question was about preemption — whether federal law blocks state warning requirements — not about the science of carcinogenicity. The IARC, which is the cancer-research arm of the World Health Organization, classified glyphosate as “probably carcinogenic to humans” (Group 2A) in 2015. The EPA disagrees. That scientific disagreement still exists. The Supreme Court did not resolve it and was never asked to.
The Court did not dismiss your case. The ruling applies to one specific legal theory — failure-to-warn based on the product label. Other theories of liability may still proceed. The scope of what survives is the single most important question for your case, and we address it in detail below.
The Court did not eliminate the settlement. Bayer’s proposed $7.25 billion settlement framework was announced separately and operates independently of the Supreme Court ruling. If your claim is eligible under that framework, the ruling does not automatically remove you from it.
The Court did not say you cannot recover. What it said is that you cannot recover under a state-law theory that would require Bayer to put a cancer warning on the Roundup label when the EPA decided no such warning was needed. That is a significant limitation — but it is a limitation on one theory, not a blanket immunity for the manufacturer.
The Missouri Case Behind the Ruling: The St. Louis Verdict Now in Jeopardy
The case that reached the Supreme Court began in St. Louis, Missouri — a venue that has been a significant battleground for Roundup and glyphosate litigation, in part because Monsanto was headquartered there before Bayer acquired the company in 2018. St. Louis city and county juries have historically been receptive to plaintiff toxic-tort theories, and the underlying case reflected that trend.
The plaintiff developed non-Hodgkin’s lymphoma after years of exposure to Roundup. A St. Louis jury awarded a $1.25 million verdict. The Missouri Court of Appeals upheld that verdict. Then Bayer appealed to the United States Supreme Court, arguing that federal pesticide law preempted the state-law failure-to-warn theory on which the verdict rested.
The Supreme Court agreed with Bayer — 7 to 2. The practical effect is that the $1.25 million verdict, upheld by the Missouri Court of Appeals, is now effectively reversed on the failure-to-warn theory. On remand, the state courts will be bound by the Supreme Court’s holding that FIFRA preempts label-based failure-to-warn claims where the EPA has not required the warning.
Here is what that $1.25 million figure represents and what it does not: it was a compensatory verdict from a St. Louis jury for a single plaintiff with non-Hodgkin’s lymphoma, tried before the Supreme Court changed the legal landscape. It illustrated the pre-ruling compensatory range in a plaintiff-friendly Missouri venue. It does not represent what a similar case would produce today — because the dominant theory that drove it has been preempted. Post-ruling, recovery for a comparable individual NHL case in Missouri is primarily channeled through the $7.25 billion settlement framework or through alternative liability theories with uncertain outcomes.
Three Things This Ruling Does NOT Mean
We want to address the three misconceptions we expect you to encounter — from friends, from the internet, and possibly from an insurance adjuster who calls you after hearing the news.
Misconception 1: “The Supreme Court said Roundup is safe.” False. The Court said federal law preempts state warning requirements. It said nothing about the safety of the product. The IARC classification of glyphosate as “probably carcinogenic to humans” remains in place. Peer-reviewed epidemiological studies associating glyphosate with non-Hodgkin’s lymphoma remain in the scientific literature. The EPA’s assessment that glyphosate is “not likely to be carcinogenic” also remains in place. The scientific debate is unchanged. What changed is which legal theories can be used to hold the manufacturer accountable.
Misconception 2: “All Roundup lawsuits are now barred.” False. The ruling bars state-law failure-to-warn claims based on the product label where the EPA has not required the warning. It does not bar design defect claims, negligent testing claims, fraud or misrepresentation claims, or breach of warranty claims — at least not categorically. Each of these surviving theories faces its own challenges, and some may face independent preemption arguments, but they are not eliminated by this ruling. The company’s own spokesperson said the ruling “should result in the dismissal of current warning-based claims and bar future failure-to-warn claims” — note the specific language: “warning-based” and “failure-to-warn.” Not “all claims.” Not “every lawsuit.”
Misconception 3: “You missed your chance — it is too late to do anything.” False, and this is the most dangerous misconception. The $7.25 billion settlement framework is still active. Statutes of limitations are still running. Evidence still exists that can be preserved. What is true is that the landscape is harder than it was before the ruling, and the urgency is greater — settlement participation windows and legal deadlines do not pause while you decide whether to act. But the door is not closed. It is narrower, and you need to walk through it deliberately.
Which Roundup Claims Face Dismissal — and Which May Still Survive
This is the section that matters most to your case. The Supreme Court ruling divides Roundup litigation into two categories: claims that are effectively dead, and claims that may still breathe.
Claims That Face Dismissal
Failure-to-warn (label-based) — This was the dominant theory in Roundup litigation. The plaintiff alleged that Monsanto failed to warn consumers that glyphosate causes cancer. The Supreme Court has now held that FIFRA preempts this theory where the EPA has not required the warning. This path is effectively closed for future claims and jeopardized for pending ones. If your entire case rests on “they should have put a cancer warning on the label,” that theory faces dismissal.
Post-ruling, failure-to-warn claims based on the label carry near-zero recovery value through litigation. They may still have some value within the settlement framework, depending on eligibility, but as standalone trial claims they are preempted.
Claims That May Survive
Design defect — This theory argues that Roundup is inherently dangerous in its formulation, regardless of what the label says. The claim is not about what the label failed to disclose — it is about whether the product itself was unreasonably dangerous when a safer alternative design existed and was economically feasible. Because this theory is not directly label-based, it may survive preemption. The challenge is proving that a safer formulation of glyphosate-based herbicide existed or was feasible, which is a demanding evidentiary burden. But the legal door is not closed by the ruling.
Negligence (failure to test / concealment) — This theory alleges that Monsanto knew or should have known of cancer risks through its own internal research but failed to conduct adequate testing or actively concealed findings. The key distinction from failure-to-warn: the duty asserted here is not tied to what the label said. It is tied to the company’s independent obligation to test its product and disclose what it found. If the company’s own scientists identified cancer risks and the company suppressed that information, that is a different wrong from failing to put a warning on a label. This theory may survive, though the precise scope of what survives will be litigated in the wake of the ruling.
Fraud and misrepresentation — This theory alleges that Monsanto misrepresented the safety of glyphosate through marketing, public statements, and scientific publications — affirmative misstatements rather than label omissions. If the claim is premised on what the company said and did beyond the label, it may survive, though state-law fraud claims may face their own independent preemption challenges. The viability of this theory post-ruling must be confirmed against the specific scope of the Court’s opinion and how lower courts interpret it.
Breach of implied warranty — This theory argues that Roundup was not fit for its ordinary purpose because it causes cancer. Warranty claims may be partially preempted if they hinge on the adequacy of warnings on the label, but merchantability theories that are independent of labeling — arguing the product itself was defective regardless of warnings — may persist.
The honest summary: the failure-to-warn theory that drove the majority of Roundup verdicts is now preempted. Alternative theories exist but carry substantial uncertainty. Each case needs a case-specific evaluation against the specific scope of the Court’s opinion, the surviving legal theories, and the settlement framework. That evaluation is what we do — and the day you call is the day it starts.
The $7.25 Billion Bayer Settlement: Who Is Covered, Who Is Not
Bayer announced a proposed $7.25 billion settlement to resolve tens of thousands of current and future Roundup lawsuits. Here is what you need to understand about that framework.
What the settlement covers: The $7.25 billion is designed to resolve tens of thousands of current and future claims. Individual settlement values under the framework will vary based on several factors: exposure duration (how long you used Roundup), diagnosis severity (the type and stage of your NHL), age at diagnosis, treatment costs, and economic impact. Based on the framework’s structure and comparable Roundup settlements, individual values likely range from five-figure base payments for less severe cases to seven-figure awards for the most severely injured claimants.
What the settlement does NOT cover: According to Bayer’s own statement, the settlement would not affect claims that stem from pending appeals or that fall outside the deal. Those claims amount to approximately $1 billion in additional exposure. If your case is on appeal, or if it falls outside the settlement’s eligibility criteria for some other reason, you are in the group with the highest uncertainty — your case is not in the settlement, and the failure-to-warn theory that might have driven its value is now preempted.
What the Supreme Court ruling means for the settlement: The ruling and the settlement are separate developments, but they interact. The ruling makes the settlement more attractive to many claimants because the primary alternative — a failure-to-warn trial claim — is now preempted. At the same time, the ruling may give Bayer leverage to offer lower individual settlement amounts, since the alternative of going to trial on a failure-to-warn theory is no longer available. The negotiation dynamics have shifted in the company’s favor, which is precisely why having a lawyer who understands the framework and can document your claim’s full value is critical.
What you should do about the settlement right now: If you believe you may be eligible, you should determine your eligibility and submit documentation before settlement deadlines close. The settlement has participation windows — deadlines by which claims must be submitted or opted in — and those windows do not pause for the Supreme Court ruling or for your deliberation about whether to participate. Waiting can permanently bar you from the framework.
We cannot promise specific settlement amounts. Individual values depend on your exposure history, your diagnosis, and your treatment records — the documentation that proves your specific claim. What we can do is help you build that documentation and evaluate whether the settlement framework serves you better than pursuing a surviving legal theory outside it.
Missouri Law After the Ruling: What Still Works in This State
The Supreme Court’s ruling overrides Missouri state law on failure-to-warn claims for pesticide labels. But Missouri law still matters — for the surviving theories, for the damages you can seek, and for the deadlines you must meet.
Missouri’s comparative fault rule: Missouri follows pure comparative fault. This means that if you are partly at fault — say, for not wearing protective equipment when applying Roundup — your damages are reduced by your percentage of fault but are not barred entirely. Even if a jury found you 50 percent at fault, you would still recover 50 percent of your damages. This is more favorable than the modified comparative fault rules in many states, which bar recovery entirely if the plaintiff is 50 or 51 percent at fault.
Missouri’s damages posture: Missouri does not impose a statutory cap on compensatory or punitive damages in product-liability actions against non-governmental defendants. This is a significant advantage. In many states, non-economic damages (pain and suffering, emotional distress, loss of quality of life) are capped at a few hundred thousand dollars. Missouri has no such cap. For surviving theories — design defect, negligent testing, fraud — this means the full measure of your harm is recoverable, including the human losses that no receipt can quantify.
Missouri’s punitive damages posture: Punitive damages may be available under Missouri law if the plaintiff proves the defendant’s conduct was reckless or willful. The preemption ruling narrows the predicate conduct that can support punitive damages on warning-based theories, but if a surviving theory — such as fraud or negligent concealment — establishes reckless conduct, Missouri’s lack of a punitive damages cap becomes a powerful lever.
Missouri’s statute of limitations: Missouri’s statute of limitations for personal injury claims is five years. For wrongful death, the deadline is three years. These clocks do not pause for the Supreme Court ruling. For toxic tort cases involving latent disease, the discovery rule typically applies — meaning the clock starts when you knew or should have known of your injury and its connection to the exposure, not when you were first exposed to Roundup. If you were diagnosed with non-Hodgkin’s lymphoma three years ago and only recently connected it to your Roundup use, your five-year clock may have started at the time of diagnosis or discovery, not at the time you last used the product. Every case turns on its own facts, and the specific accrual date for your claim must be evaluated against Missouri law.
There is an important caution here: some states impose an outer deadline called a statute of repose that can cut off a claim even before discovery. We cannot promise the discovery rule protects you without checking the specific deadlines that apply to your situation. This is one of the first things we evaluate when you call.
Missouri’s agricultural sector and exposure population: Missouri has a significant agricultural economy — corn, soybeans, cattle, and other crops that depend on herbicide application. Farmers, farmworkers, commercial applicators, and homeowners across the state have used Roundup extensively. Missouri’s agricultural sector represents a large population of potential glyphosate-exposure claimants, and the St. Louis venue — Monsanto’s former hometown — has been a focal point of the litigation. The Supreme Court ruling changes the legal landscape for all of these Missouri claimants, but it does not change the fact that the exposure happened, the diagnoses are real, and the harm is documented.
The Science Is Not Settled: IARC vs. EPA on Glyphosate
One of the most important things to understand about the Roundup litigation — and about your case — is that the scientific disagreement about glyphosate and cancer is real and unresolved. Two authoritative bodies have reached different conclusions:
The IARC classification: The International Agency for Research on Cancer, which is the specialized cancer agency of the World Health Organization, classified glyphosate as “probably carcinogenic to humans” — Group 2A — in 2015. Group 2A means the evidence is limited in humans but sufficient in animals, and there is strong mechanistic evidence. This classification is based on peer-reviewed epidemiological studies and animal experiments. Some studies associate Roundup’s key ingredient with non-Hodgkin’s lymphoma specifically.
The EPA assessment: The EPA reviewed glyphosate and concluded it is “not likely to be carcinogenic to humans when used according to label instructions.” The EPA did not require a cancer warning on Roundup labels. This assessment is the basis for the FIFRA preemption ruling — because the EPA, within the federal labeling framework, decided no cancer warning was needed, states cannot impose one through tort law.
Why this matters for your case: The Supreme Court ruling was about which legal theories you can use, not about which scientific assessment is correct. The IARC classification remains a point of scientific disagreement with the EPA’s assessment and may support non-label-based theories of liability. If your case proceeds on a design defect or negligent testing theory, the IARC classification and the peer-reviewed epidemiological literature associating glyphosate with NHL become central to proving general causation — the proposition that glyphosate can cause the disease you have.
The defense will point to the EPA assessment and say the government’s own regulator found no cancer risk. The counter is that the IARC — the world’s leading cancer research authority — disagreed, and that the EPA’s assessment has been criticized and is subject to ongoing scientific debate. The science is the foundation for any surviving liability theory, and it is not as one-sided as the defense would have a jury believe.
The Medicine: Non-Hodgkin’s Lymphoma and What It Costs
If you developed non-Hodgkin’s lymphoma after years of Roundup exposure, you already know what the disease looks like from the inside. We are not going to describe it to you as if you have not lived it. But we do need to talk about what it costs — because documenting that cost is how a case is built.
What NHL is: Non-Hodgkin’s lymphoma is a cancer of the lymphatic system — specifically of the lymphocytes, a type of white blood cell. It begins in the lymph nodes or in lymphoid tissue and can spread throughout the body. There are many subtypes, ranging from indolent (slow-growing) to aggressive (fast-growing). The diagnosis changes everything about the treatment path and the prognosis.
How it is treated: Treatment depends on the subtype and stage but commonly includes chemotherapy, immunotherapy (such as monoclonal antibody drugs), radiation therapy, and in some cases stem-cell transplants. Each of these treatments carries its own burden — the nausea, the fatigue, the immune suppression, the hair loss, the fear of recurrence. Some patients face years of maintenance therapy. Some face relapse and retreatment. The medical records that document your diagnosis, your pathology reports, your treatment plans, and your oncology follow-up are the proof of your injury — and they are the foundation of your damages.
What it costs: Cumulative medical costs for NHL treatment often exceed hundreds of thousands of dollars. A single course of chemotherapy can run tens of thousands. Immunotherapy drugs can cost more. A stem-cell transplant — which some NHL patients require — can push costs into the high six figures. These are economic damages: past and future medical expenses that can be documented from your medical bills and insurance records.
The human costs beyond the bills: Economic damages are the beginning, not the end. You also have lost wages — the time you could not work during treatment and recovery. You have diminished earning capacity — the future income you will not earn because of the disease and its aftermath. You have pain and suffering — the physical and emotional toll of living with cancer. You have loss of quality of life — the activities, the relationships, the plans that the disease stole or diminished. You have fear of recurrence — the constant background anxiety that the cancer will return. Missouri law allows recovery for all of these categories, and Missouri does not cap them. A complete damages case counts every one.
Survival and wrongful death: If the exposed individual has died, Missouri law provides two parallel claims. A survival claim captures the damages the deceased person accrued before death — their pain, their medical expenses, their lost wages from the period between injury and death. A wrongful death claim covers the beneficiaries’ losses — the financial support the family will go without, the companionship that was taken, the grief that does not have a price tag but has a legal value. Missouri’s three-year wrongful death statute of limitations is shorter than the five-year personal injury limit, and it runs from the date of death — not the date of exposure or even the date of diagnosis.
The Defendant: Bayer AG and Monsanto — the Corporate Structure
You are not suing a local company. You are up against one of the largest pharmaceutical and chemical conglomerates in the world, and understanding who you are really fighting matters for your case.
Bayer AG is the German parent corporation that acquired Monsanto in 2018. When Bayer bought Monsanto, it assumed the liability for Roundup litigation — tens of thousands of lawsuits claiming the herbicide causes cancer. Bayer has been orchestrating the defense strategy and the $7.25 billion settlement framework since the acquisition.
Monsanto Company is the St. Louis-based manufacturer that developed, manufactured, and marketed Roundup for decades before the Bayer acquisition. Monsanto controlled the scientific research, the regulatory submissions to the EPA, and the marketing strategy for glyphosate-based products. The internal research documents, emails, and scientific communications from Monsanto’s era — evidence of what the company knew about cancer risks and when — are central to the surviving liability theories.
Potential downstream distributors and retailers — entities in the chain of distribution may also face claims under state product-liability theories, though the preemption ruling narrows failure-to-warn exposure for these defendants as well. The viability of distributor claims post-ruling must be confirmed against the specific scope of the Court’s opinion.
The corporate structure matters because it affects who you sue, what evidence you can reach, and what insurance or corporate assets stand behind your claim. Bayer is a deep-pocket multinational defendant with the resources to fight every case — and the resources to pay when the evidence and the law demand it. The toxic tort lawyers who handle these cases need to understand the corporate structure, the insurance posture, and the settlement framework to build a claim that reaches the right defendant and the right source of recovery.
Evidence You Must Preserve Right Now — and How Fast It Disappears
Every toxic tort case is a race against evidence decay. The ruling does not change that — it makes it more urgent, because the surviving theories demand more specific proof than the failure-to-warn theory did.
Medical records — ongoing but perishable: Your NHL diagnosis, pathology reports, treatment history, and oncology treatment plans prove your specific injury, your damages, and the temporal relationship to your exposure. These records are ongoing — they continue to be generated as long as you receive treatment — but they must be preserved through a qualified medical authorization immediately. Hospitals and oncology practices operate on their own retention schedules, and older records can be purged or archived in ways that make them difficult to retrieve. Request your complete medical file now, not when a lawyer asks for it six months from now.
Exposure documentation — high urgency, fast-dying: Documentation of your Roundup and glyphosate exposure history is the most perishable evidence in your case. Purchase receipts, employment records, agricultural application logs, and witness statements establish specific causation by quantifying the duration, frequency, and intensity of your exposure. This evidence is high-priority because memories fade, records are discarded, and agricultural operation records may be routinely purged on short retention cycles. If you used Roundup on a farm, the application logs that show how often and how much may be gone within a few years. If you bought it at a hardware store, the receipt may already be lost. Write down everything you remember now — the brands, the years, the frequency, the equipment you used — while your memory is fresh.
Historical product labels — moderate urgency, partially discoverable: Historical Roundup product labels and marketing materials from the period of your exposure demonstrate what warnings were present and what representations were made at the relevant time. These are critical even post-ruling for non-label theories and fraud claims. Monsanto and Bayer archives are discoverable, but access may be restricted by existing protective orders and settlement terms. Your lawyer can reach these documents through discovery, but only if your case is filed and the discovery requests are served.
Monsanto and Bayer internal research documents — moderate urgency, access-restricted: Internal research documents, emails, and scientific communications regarding glyphosate carcinogenicity support design defect, negligence, and fraud theories by showing what the company knew and when. These documents exist in corporate archives and in prior discovery productions from the Roundup MDL, but access may be restricted by existing protective orders and settlement terms. For surviving theories, these documents are the heart of the case — they are what separate “they should have warned” (preempted) from “they knew and concealed” (potentially surviving).
EPA registration files — low urgency, stable: EPA registration files, FIFRA compliance correspondence, and regulatory communications between Monsanto and the EPA are public record and relatively stable. These define the scope of what the EPA required and what the EPA knew — central to the preemption analysis and to identifying whether any non-label regulatory duties were breached. They are not going to disappear.
Peer-reviewed literature — low urgency, stable: The IARC monograph and peer-reviewed epidemiological literature on the glyphosate and non-Hodgkin’s lymphoma association are published and stable. These support general causation expert testimony — the scientific foundation for any surviving liability theory. Your expert witnesses will rely on this literature, and it is not going anywhere.
The preservation letter: The preservation or spoliation letter is the first thing a lawyer sends in a toxic tort case. It is a formal demand that the defendant and every relevant third party preserve all evidence — internal documents, emails, research files, regulatory correspondence, product samples, and historical records. The letter creates a legal obligation: if the defendant lets evidence die after receiving the letter, the court can impose sanctions, including an adverse-inference instruction that tells the jury they may assume the lost evidence was as bad as the plaintiff says. The preservation letter goes out the day you call, not after weeks of deliberation.
What a Roundup Cancer Case May Be Worth After the Ruling
We are going to give you honest numbers, not promises. Case value after the Supreme Court ruling depends on which path your case takes.
Settlement-eligible claims under the $7.25B framework: Individual settlement values will vary based on exposure duration, diagnosis severity, age at diagnosis, and treatment costs. Based on the framework’s structure and comparable Roundup settlements, individual values likely range from approximately $25,000 at the low end for less severe cases with shorter exposure histories to $1,500,000 or more at the high end for the most severely injured claimants with long, well-documented exposure and aggressive NHL subtypes requiring extensive treatment. Most settlement-eligible claims will fall somewhere in the middle of that range, driven by the specific facts of your exposure and your medical history.
Failure-to-warn claims facing dismissal: Post-ruling, standalone failure-to-warn claims face dismissal and carry near-zero recovery value through litigation. They may retain some value within the settlement framework if the claim is eligible, but as trial claims they are preempted.
Alternative-theory cases (design defect, negligent testing, fraud): These claims may still command significant value if liability can be established, because Missouri does not cap compensatory or punitive damages. But the uncertainty is substantial and case-specific. The $1.25 million Durnell verdict — now effectively reversed — represented the pre-ruling trial ceiling for a comparable individual NHL case in a plaintiff-friendly Missouri venue. Post-ruling, a surviving-theory case that actually wins at trial could exceed that figure (because Missouri has no damages caps), but the probability of getting there is lower and the path is harder.
Claims outside the settlement (~$1B in exposure per Bayer): These claims face the highest uncertainty. They are not in the settlement, the primary trial theory is preempted, and the surviving theories are untested in the post-ruling landscape. A case-specific evaluation is essential.
The honest framing: this is not the moment to assume your case is worthless, and it is not the moment to assume it is worth millions. It is the moment to get a case-specific evaluation from a lawyer who understands the ruling, the settlement framework, and the surviving theories. You can learn more about how case value is built by watching Ralph Manginello explain what your case is worth.
Past results depend on the facts of each case and do not guarantee future outcomes.
The Defense Playbook After the Supreme Court Ruling — and How We Counter Each Play
The defense playbook changed the moment the ruling came down. Here are the plays you should expect, and how we counter each one.
Play 1: “The Supreme Court said Roundup is safe.”
This is the first thing an adjuster or defense lawyer will say, and it is a lie by implication. The Court said federal law preempts state warning requirements. It said nothing about safety. The counter: the ruling was about preemption doctrine, not about the carcinogenicity of glyphosate. The IARC classification stands. The peer-reviewed literature stands. The science is not resolved — one legal theory is.
Play 2: “Your entire claim is preempted — give up.”
The defense will try to expand the ruling beyond its actual scope. The ruling preempted label-based failure-to-warn claims. It did not categorically bar design defect claims, negligent testing claims, fraud claims, or warranty claims. The counter: we plead every surviving theory, tie each to specific facts about what Monsanto did and knew beyond the label, and force the defense to litigate each theory on its merits. The ruling narrowed the field — it did not clear it.
Play 3: “Take this quick settlement offer before the framework closes.”
After a ruling that weakens the plaintiff’s primary trial theory, the defense may push a low settlement offer and create artificial urgency. The counter: we evaluate any offer against the full value of your claim — your exposure history, your diagnosis, your treatment costs, your lost earnings, your pain and suffering, and the leverage that surviving theories and Missouri’s lack of damages caps provide. A fast offer from the defense is designed to close your case before you understand what it is worth. We do not let urgency from the other side dictate the value of your case.
Play 4: “The EPA says glyphosate does not cause cancer.”
The defense will lean on the EPA assessment. The counter: the IARC — the world’s leading cancer research authority — classified glyphosate as probably carcinogenic. The EPA’s assessment has been criticized and is subject to ongoing scientific debate. Two authoritative bodies disagree. The EPA’s position is one view, not the final word, and in front of a jury the disagreement itself is powerful evidence that the safety of the product is not settled.
Play 5: “You waited too long — the statute of limitations has run.”
The defense will check your filing date against the statute of limitations and argue the clock has expired. The counter: for latent diseases like NHL, the discovery rule typically applies — the clock starts when you knew or should have known of your injury and its connection to the exposure, not when you were first exposed. If you were diagnosed three years ago and only recently connected it to Roundup, your clock may have started recently. But this is not automatic, and the specific accrual date for your claim must be evaluated against Missouri law and any statute of repose that may apply. We check this first.
Your First Steps: The Roadmap After the Ruling
If you used Roundup and developed non-Hodgkin’s lymphoma, the Supreme Court ruling changed your legal options but it did not eliminate them. Here is what you should do — not next week, not after you think about it, but now.
Step 1: Gather your medical records. Request your complete medical file from your oncologist, your hospital, and every treating provider. You need your pathology report confirming the NHL diagnosis, your treatment records, your chemotherapy or immunotherapy records, your imaging, and your follow-up notes. These prove your injury and your damages. Medical records can be purged on retention schedules — get them now.
Step 2: Document your exposure history. Write down everything you can remember about your Roundup use. What brands did you use? What years? How often — weekly, monthly, seasonally? How did you apply it — hand sprayer, backpack sprayer, tractor-mounted rig? Where did you use it — your farm, your garden, your employer’s fields? Did you mix concentrates? Did you wear protective equipment? Every detail matters. Memories fade and records are discarded — write it down now.
Step 3: Check your settlement eligibility. The $7.25 billion settlement framework has participation windows and eligibility criteria. If your claim is eligible, you need to submit documentation before the deadlines close. We can help you determine eligibility and assemble the documentation the framework requires.
Step 4: Get a case-specific legal evaluation. The ruling changed the landscape, but the landscape is not flat. Your case may have a viable design defect theory, a negligent testing theory, a fraud theory, or a combination. Or your strongest path may be the settlement framework. Or — honestly — the ruling may have gutted your case, and you need to hear that from a lawyer who will tell you the truth rather than string you along. The evaluation is free. The call costs nothing. And the answer — whatever it is — is worth having before you make decisions you cannot undo.
Step 5: Do not sign anything from the defense or the settlement administrator without legal review. A release is a permanent surrender of your right to sue. A settlement election may lock you into a framework that pays you less than your case is worth. Before you sign anything, have a lawyer read it and tell you what you are giving up.
Step 6: Do not give a recorded statement. If an insurance adjuster or a representative of the settlement administrator calls and asks you to “just tell us what happened” on a recording, do not do it. That recording is built to be quoted against you. Say nothing until you have a lawyer.
Frequently Asked Questions
Can I still sue Bayer after the Supreme Court Roundup ruling?
Yes, but not on a failure-to-warn theory. The ruling preempts state-law claims that would require Bayer to put a cancer warning on the Roundup label when the EPA did not require one. Other theories — design defect, negligent testing, fraud or misrepresentation, and breach of warranty — may still survive, though each faces its own challenges. Your case needs a case-specific evaluation to determine which theories apply to your facts.
Does the Supreme Court ruling mean Roundup is safe?
No. The ruling was about federal preemption — whether federal pesticide law blocks states from imposing their own warning requirements. It was not about the safety of the product. The IARC classification of glyphosate as “probably carcinogenic to humans” remains in place. The scientific debate about glyphosate and cancer is unchanged by the ruling.
What happened to the $1.25 million Missouri verdict?
The St. Louis jury verdict of $1.25 million, which the Missouri Court of Appeals upheld, is effectively reversed by the Supreme Court’s preemption ruling. On remand, the state courts will be bound by the holding that FIFRA preempts label-based failure-to-warn claims. The verdict illustrates the pre-ruling compensatory range in a plaintiff-friendly Missouri venue, but it does not represent what a similar case would produce today.
Is the $7.25 billion Bayer settlement still available?
Yes. The settlement framework was announced separately from the Supreme Court ruling and operates independently. If your claim is eligible under the framework, the ruling does not automatically remove you from it. However, settlement participation windows and eligibility criteria have deadlines that do not pause for the ruling. You should determine your eligibility and submit documentation before those deadlines close.
How long do I have to file a Roundup cancer claim in Missouri?
Missouri’s statute of limitations for personal injury claims is five years. For wrongful death, it is three years from the date of death. For toxic tort cases involving latent disease, the discovery rule typically applies — meaning the clock may start when you knew or should have known of your injury and its connection to the exposure, not when you were first exposed. The specific accrual date for your claim must be evaluated against Missouri law. Do not assume you have plenty of time — the clock is running regardless of the Supreme Court ruling.
What is non-Hodgkin’s lymphoma and how is it connected to Roundup?
Non-Hodgkin’s lymphoma is a cancer of the lymphatic system that begins in white blood cells called lymphocytes. Some peer-reviewed epidemiological studies associate glyphosate — the active ingredient in Roundup — with an increased risk of developing NHL. The IARC classified glyphosate as “probably carcinogenic to humans” in 2015. The EPA concluded it is “not likely to be carcinogenic.” This scientific disagreement is central to the litigation and remains unresolved.
How much is my Roundup cancer case worth?
Case value depends on your exposure history, your diagnosis, your treatment costs, your lost wages, your pain and suffering, and which legal path your case takes. Settlement-eligible claims under the $7.25 billion framework likely range from approximately $25,000 to $1,500,000 depending on the severity of your case. Alternative-theory cases tried in court could exceed those figures because Missouri does not cap damages, but the probability of winning at trial is lower after the ruling. A case-specific evaluation is the only honest way to estimate value.
What evidence do I need for a Roundup cancer case?
You need medical records establishing your NHL diagnosis and treatment, documentation of your Roundup and glyphosate exposure history (purchase receipts, employment records, application logs, witness statements), and any historical product labels or marketing materials from the period of your exposure. Internal Monsanto and Bayer research documents regarding glyphosate carcinogenicity may be obtainable through discovery. The preservation letter that freezes corporate evidence goes out the day you call a lawyer — before those records can be legally destroyed.
If my loved one died from non-Hodgkin’s lymphoma after using Roundup, can I still file a claim?
Yes, but the timeline is shorter. Missouri’s wrongful death statute of limitations is three years from the date of death. A survival claim may also be available for damages the deceased accrued before death. The Supreme Court ruling preempts the failure-to-warn theory in wrongful death cases as well, but surviving theories — design defect, negligent testing, fraud — may still proceed. If your loved one’s death was recent, do not wait. The three-year clock is unforgiving.
Should I take the settlement offer or go to trial?
This depends entirely on the facts of your case. The settlement framework offers certainty — a known process with defined value ranges. Going to trial on a surviving theory offers the potential for a larger recovery (because Missouri does not cap damages) but carries the risk of losing and getting nothing. The ruling made trial riskier by preempting the primary theory that drove past verdicts. A lawyer who understands the ruling, the settlement framework, and your specific facts can help you make this decision — but no one should make it for you without a full evaluation.
Why Attorney911
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm that takes cases in Missouri, working with local counsel where required. We do not claim an office in Missouri, and we will not pretend to be something we are not. What we are is a firm with 24 years of experience fighting for people injured by corporations, with more than $50 million in aggregate recoveries, and with the specific knowledge this moment demands.
Ralph P. Manginello is our Managing Partner — 27+ years of trial practice, admitted to Texas bars and federal courts, a journalist before he was a lawyer, and a competitor who hates losing. He leads a firm that has recovered millions for injured clients, including a $5 million brain-injury settlement, a $3.8 million amputation settlement, and a $2.5 million truck-crash recovery. He is currently lead counsel in an active $10 million hazing lawsuit. He does not take cases he cannot win, and he will tell you the truth about yours.
Lupe Peña is our associate attorney — a former insurance-defense attorney who spent years inside a national defense firm, in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. He sat on the other side of the table. He knows how claims are valued, how reserves are set, how surveillance is deployed, and how delay tactics work — and now he uses that knowledge for injured clients. He is fluent in Spanish and conducts full consultations in Spanish without an interpreter. If your family speaks Spanish at home, your case does not need a translation — it needs Lupe.
The firm operates on contingency. We charge 33.33% before trial and 40% if the case goes to trial. We do not get paid unless we win your case. The consultation is free. The call costs nothing. And we have 24/7 live staff — not an answering service, but people who can take your call at any hour and start the process.
Hablamos Español. If your family communicates in Spanish, we serve you fully in your language — from the first consultation through every step of the case.
The Supreme Court ruling changed the Roundup litigation. It did not change the fact that you were exposed, that you got sick, and that a company profited from a product that may have caused your cancer. It did not change the settlement framework. It did not change Missouri’s lack of damage caps. And it did not change our commitment to evaluating your case honestly and fighting for everything it is worth.
Call us at 1-888-ATTY-911 (1-888-288-9911). The consultation is free. There is no fee unless we win. And the call you make today may be the most important decision in your case — because the deadlines are running, the evidence is aging, and the settlement windows are closing, whether the Supreme Court ruled or not.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential.